PDCD1 and neoplasm: PD-1 and its ligands, PD-L1/2, are inhibitory homologues of CD28 and B7, respectively, and hence, their interaction inhibits T-cell proliferation, promotes central and peripheral T-cell tolerance, and decreases tumor cell apoptosis (Zhang et al., 2004).